Telitacicept - CAS 2136630-26-5

Telitacicept (RC18), a fully human TACI-Fc fusion protein, acts as a dual inhibitor of B lymphocyte stimulator (BLyS) and APRIL (a proliferation-inducing ligand), effectively impeding B lymphocyte proliferation. This compound is applicable in researching B-cell autoimmune diseases [1].

TNF

Apoptosis

2136599

-20°C

Ice Packs

Inhibitory Antibodies